DVL3 and Fabry disease: In our study, we also found that orally administered niclosamide inhibited the canonical Wnt signaling pathway activation, downregulated Dvl3, decreased downstream β-catenin signaling, and exerted anti-extension of AL and VCD in the FD myopia mice and APCMin mice.